Prevalence of Antiphospholipid and Antiplatelet Antibodies in Human Immunodeficiency Virus (HIV)-Infected Chilean Patients

Journal of Clinical Laboratory Analysis

Volumn 17, Issue 6, 2003, Pages 209-215

  Palomo, Iván ^a   Alarcón, Marcelo ^a   Sepulveda, Cecilia ^b   Pereira, Jaime ^c   Espinola, Ricardo ^d   Pierangeli, Silvia ^d  

^a UNIVERSIDAD DE TALCA   (Chile)

^b HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^c PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^d MOREHOUSE SCHOOL OF MEDICINE   (United States)

Author keywords

Anti cardiolipin antibodies; Antiphospholipid antibodies; Antiplatelet antibodies; HIV infection

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; GLYCOPROTEIN IB; GLYCOPROTEIN IB IX COMPLEX; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY; THROMBOCYTE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILE; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUPUS ANTICOAGULANT TEST; MAJOR CLINICAL STUDY; MALE; SEROPREVALENCE; THROMBOCYTE COUNT; THROMBOCYTOPENIA; THROMBOSIS;

ADULT; ANTIBODIES, ANTICARDIOLIPIN; AUTOANTIBODIES; BETA 2-GLYCOPROTEIN I; BLOOD PLATELETS; CHILE; FEMALE; GLYCOPROTEINS; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; PROTHROMBIN; THROMBOCYTOPENIA; THROMBOSIS;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0346328425     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcla.10093     Document Type: Article

References (56)

1. Hughes G, Harris E, Gharavi A. The anticardiolipin syndrome. J Rheumatol 1986;13:486-489.
2. Asherson R, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: history, definition, classification and differential diagnosis. In: Asherson R, Cervera R, Piette JC, Shoenfeld Y, editors. The antiphospholipid syndrome. New York: CRC Press; 1996. p 3-12.
3. He R, Reid DM, Jones CE, Shulman NR. Spectrum of Ig classes, specificities, and titers of serum antiglycoproteins in chronic idiopathic thrombocytopenic purpura. Blood 1994;83:1024-1032.
4. Shulman R, Reid DM. Platelet immunology. In: Colman R, Hirsh J, Marder V, Salzman E, editors. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia, PA: Lippincott Company; 1994. p 414-468.
5. Rand ML, Wright JF. Idiopathic thrombocytopenic purpure virus-associated. Transfus Sci 1998;19:253-259.
6. Roubey RA. Immunology of the antiphospholipid syndrome: antibodies, antigens, and autoimmune response. Thromb Haemost 1999;82:656-661.
7. Pierangeli S, Gharavi AE, Harris EN. Anticardiolipin testing. In: Kamashta MA, editor. Hughes syndrome, antiphospholipid syndrome. London: Springer; 2000. p 205-212.
8. Mackie IJ, Donohe S, Machin SJ. Lupus anticoagulant measurement. In: Kamashta MA, editor. Hughes syndrome, antiphospholipid syndrome. London: Springer; 2000. p 214-224.
9. de Larranaga GF, Forastiero RR, Carreras LO, Alonso BS. Different types of antiphospholipid antibodies in AIDS: a comparison with syphilis and the antiphospholipid syndrome. Thromb Res 1999;96:19-25.
10. Galvez J, Martin I, Medino D, Pujol E. Thrombophebitis in a patients with abute Q fever and anticardiolipin antibodies. Med Clin (Barc) 1998;108:396-397.
11. Mackworth-Young CG, Harris EN, Steere AC, et al. Anticardiolipin antibodies in Lyme disease. Arthritis Rheum 1998;31:1052-1056.
12. Catteau B, Delaporte E, Hachulla E, Piette F, Bergoend H. Mycoplasma infection with Stevens Johnson syndrome and antiphospholipid antibodies, apropos of 2 cases. Rev Med Interne 1995;16:10-14.
13. Santiago MB, Cossermelli W, Tuma MF, Pinto MN, Oliveira RM. Anticardiolipin antibodies in patients with infectious diseases. Clin Rheumatol 1989;8:23-28.
14. 2-Glycoprotein I-dependence of anticardiolipin antibodies in multibacillary leprosy patients. Lepr Rev 1998;69:376-381.
15. 2-GPI. J Autoimmun 1999;13:347-355.
16. Cheng HM, Khairullah NS. Induction of antiphospholipid autoantibody during cytomegalovirus infection. Clin Infect Dis 1997;25:1493-1494.
17. Manco-Johnson MJ, Nuss R, Key N, et al. Lupus anticoagulant and protein S deficiency in children with post-varicella purpura fulminans or thrombosis. J Pediatr 1996;128: 319-23.
18. 2 glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol 1998;101:468-474.
19. Sorice M, Pittoni V, Griggi T, et al. Specificity of antiphospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies. Clin Exp Immunol 2000;120:301-306.
20. 2-glycoprotein I in HIV-seropositive patients: relationship with endothelial activation and antimalonic dialdehyde antibodies. Eur J Clin Invest 1998;28: 115-122.
21. 2-glycoprotein I (apolipoprotein H)-independent anticardiolipin antibody in human immunodeficiency virus-1-positive and -negative hemophiliacs. Am J Hematol 1993;43:146-148.
22. Capel P, Janssens A, Clumeck N, et al. Anticardiolipin antibodies (ACA) are most often not associated with lupus anticoagulan (LAC) in human immunodeficiency virus (HIV) infection. Am J Hematol 1991;37:234-238.
23. 2 glycoprotein I antibodies in HIV infection. Clin Immunol Immunopathol 1995;77:69-74.
24. Abuaf N, Laperche S, Rajoely B, et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 1997;77:856-861.
25. Ankri A, Bonmarchand M, Coutellier A, Herson S, Karmochkine M. Antiphospholipid antibodies are an epiphenomenon in HIV-infected patients. AIDS 1999;13:1282-1283.
26. Magnac C, de Saint Martin J, Pidard D, Legrand C, Dighiero G. Platelet antibodies in serum of patients with human immunodeficiency virus (HIV) infection. AIDS Res Hum Retroviruses 1990;6:1443-1449.
27. Riccio A, Natale D, Fratellanza G, et al. The lack of correlation between the positivity of antiplatelet antibodies and the presence of thrombocytopenia in course of HIV infection. Boll Soc Ital Biol Sper 1993;69:203-208.
28. Belmonte MA, Garcia-Portales R, Domenech I, Fernandez-Nebro A, Camps MT, De Ramon E. Avascular necrosis of bone in human immunodeficiency virus infection and antiphospholipid antibodies. J Rheumatol 1993;20:1425-1428.
29. Thirumalai S, Kirshner HS. Anticardiolipin antibody and stroke in an HIV-positive patient. AIDS 1994;8:1019-1020.
30. Louache F, Vainchenker W. Thrombocytopenia in HIV infection. Curr Opin Hematol 1994;1:369-372.
31. Loizou S, McCrea JD, Rudge AC, Reynolds R, Boyle CC, Harris EN. Measurement of anticardiolipin antibodies by enzyme-linked immunosobent assay ELISA: standarization and quantitation of results. Clin Exp Immunol 1985;62:738-45.
32. Harris EN. Antiphospholipid antibodies. Br J Haematol 1990;74:1-9.
33. Reber G, Arvieux J, Comby E, et al. Multicenter evaluation of nine commercial kits for the quantitation of anticardiolipin antibodies. The Working Group on Methodologies in Haemostasis from the GEHT (Groupe d'Etudes sur l'Hemostase et la Thrombose). Thromb Haemost 1995;73:444-452.
34. Schleider M, Nachman R, Jaffe E, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976;48:499-509.
35. Exner T, Richard KA, Kronenberg H. A sensitive test demonstrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978;40:143-151.
36. 2GPI and throughs that of IgG antiphospholipid antibodies. Studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 1994;7: 335-348.
37. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995;74:1120-1125.
38. Winiarski J, Ekelund E. Antibody binding to platelet in acute and chronic idiopathic thrombocytopenic purpura: a platelet membrane ELISA for the detection of antiplatelet antibodies in serum. Clin Exp Immunol 1987;63:459-465.
39. Furihata K, Nugent D, Bissonette A, Aster R, Kunicki T. On association of platelet specific alloantigen, pena, with glycoprotein IIIa. Evidence for heterogeneity of glycoprotein IIIa. J Clin Invest 1987;80:1624-1630.
40. Gonzalez-Conejero R, Rivera J, Rosillo MC, Cano A, Rodriguez T, Vicente V. Association of autoantibodies against platelet glycoproteins Ib/IX and IIb/IIIa, and platelet-reactive anti-HIV antibodies in thrombocytopenic narcotic addicts. Br J Haematol 1996;93:464-471.
41. Palomo I, Pereira J, Alarcón M, et al. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;140:336-341.
42. Toulon P. Hemostasis and human immunodeficiency virus (HIV) infection. Ann Biol Clin 1998;56:253-260.
43. 2 glycoprotein I and anticardiolipin antibodies in leptospirosis, syphilis and Kala-azar. Clin Exp Rheumatol 2001;19:425-430.
44. Keeling DM, Birley H, Machin SJ. Multiple transient ischaemic attacks and a mild thrombotic stroke in a HIV-positive patient with anticardiolipin antibodies. Blood Coagul Fibrinolysis 1990;1:333-335.
45. Orbea-Rios L, Venero Gomez J, Justo Alpanes E, Colmenero Camacho M, Rodriguez Pinero J. Deep venous thrombosis of inferior extremity in a patient with AIDS and anticardiolipin antibodies. An Med Interna 1999;16:268.
46. Leder AN, Flansbaum B, Zandman-Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus 2001;10:370-374.
47. Murphy MF, Metcalfe P, Waters AH, et al. Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 1987;66:337-340.
48. Rossi G, Gorla R, Stellini R, et al. Prevalence, clinical and laboratory features of thrombocytopenia in individuals HIV-infected. AIDS Res Hum Retroviruses 1990;6:261-269.
49. Perkocha LA, Rodgers GM. Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical consideration. Am J Hematol 1988;29:94-105.
50. Walsh CM, Nardi MA, Karpatkin S. On the mechanism of thrombocytopenic purpura in sexually active homosexual men. N Engl J Med 1984;311:635-639.
51. Karpatkin S, Nardi M. Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest 1992;89:356-364.
52. Karpatkin S, Nardi M, Green D. Platelet and coagulation defects associated with HIV-1-infected. Thromb Haemost 2002;88: 389-401.
53. Bettaieb F, Oksenhendler E, Duedardi N, Bierling P. Cross-reactive antibodies between HIV-GP120 and plateles GP IIIa (CD61) in HIV-related inmune trombocytopenic purpura. Clin Exp Immunol 1996;103:19-23.
54. 3). J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:385-390.
55. Chia WK, Blanchette V, Mody M, Wright JF, Freedman J. Characterization of HIV-1-specific antibodies and HIV-1-crossreactive antibodies to platelets in HIV-1-infected haemophiliac patients. Br J Haematol 1998;103:1014-1022.
56. Palomo I, Pereira J, Alarcon M, Larrain AM, Pinochet C, Vasquez M, Velez MT, Leon M, Espinola R, Pierangeli S. Antiphospholipid antibodies in Chilean patients with systemic lupus erythematosus. J Lab Clin Med 2002;140:336-341.